Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benedetta Maria Bonora

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Cardiovascular Diabetology|February 11, 2017
DPP-4 inhibition has no acute effect on BNP and its N-terminal pro-hormone measured by commercial immune-assays. A randomized cross-over trial in patients with type 2 diabetesGian Paolo Fadini, Benedetta Maria Bonora, Mattia Albiero, et al.
Diabetologia|September 15, 2023
Improved prediction of long-term kidney outcomes in people with type 2 diabetes by levels of circulating haematopoietic stem/progenitor cellsBenedetta Maria Bonora, Mario Luca Morieri, Marella Marassi, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 8, 2022
Glycaemic Control Achieves Sustained Increases of Circulating Endothelial Progenitor Cells in Patients Hospitalized for Decompensated Diabetes: An Observational StudyBenedetta Maria Bonora, Roberta Cappellari, Marco Grasso, et al.
Cardiovascular Diabetology|January 19, 2018
p66Shc gene expression in peripheral blood mononuclear cells and progression of diabetic complicationsGian Paolo Fadini, Mattia Albiero, Benedetta Maria Bonora, et al.
Atherosclerosis|October 11, 2017
Shift of monocyte subsets along their continuum predicts cardiovascular outcomesRoberta Cappellari, Marianna D'Anna, Benedetta Maria Bonora, et al.
Diabetologia|April 20, 2020
Diabetes mellitus impairs circulating proangiogenic granulocytesRoberta Cappellari, Marianna D'Anna, Lisa Menegazzo, et al.
Diabetes Research and Clinical Practice|August 28, 2021
Outcomes of patients with type 2 diabetes treated with SGLT-2 inhibitors versus DPP-4 inhibitors. An Italian real-world study in the context of other observational studiesEnrico Longato, Benedetta Maria Bonora, Barbara Di Camillo, et al.
European Heart Journal|January 1, 2020
Circulating stem cells and cardiovascular outcomes: from basic science to the clinicGian Paolo Fadini, Anurag Mehta, Devinder Singh Dhindsa, et al.
Diabetes Care|June 28, 2015
Effects of Age, Diabetes, and Vascular Disease on Growth Differentiation Factor 11: First-in-Human StudyGian Paolo Fadini, Lisa Menegazzo, Benedetta Maria Bonora, et al.
Cardiovascular Diabetology|April 6, 2017
Effects of the SGLT2 inhibitor dapagliflozin on HDL cholesterol, particle size, and cholesterol efflux capacity in patients with type 2 diabetes: a randomized placebo-controlled trialGian Paolo Fadini, Benedetta Maria Bonora, Giancarlo Zatti, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Cardiovascular Diabetology|February 11, 2017
DPP-4 inhibition has no acute effect on BNP and its N-terminal pro-hormone measured by commercial immune-assays. A randomized cross-over trial in patients with type 2 diabetesGian Paolo Fadini, Benedetta Maria Bonora, Mattia Albiero, et al.
Diabetologia|September 15, 2023
Improved prediction of long-term kidney outcomes in people with type 2 diabetes by levels of circulating haematopoietic stem/progenitor cellsBenedetta Maria Bonora, Mario Luca Morieri, Marella Marassi, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 8, 2022
Glycaemic Control Achieves Sustained Increases of Circulating Endothelial Progenitor Cells in Patients Hospitalized for Decompensated Diabetes: An Observational StudyBenedetta Maria Bonora, Roberta Cappellari, Marco Grasso, et al.
Cardiovascular Diabetology|January 19, 2018
p66Shc gene expression in peripheral blood mononuclear cells and progression of diabetic complicationsGian Paolo Fadini, Mattia Albiero, Benedetta Maria Bonora, et al.
Atherosclerosis|October 11, 2017
Shift of monocyte subsets along their continuum predicts cardiovascular outcomesRoberta Cappellari, Marianna D'Anna, Benedetta Maria Bonora, et al.
Diabetologia|April 20, 2020
Diabetes mellitus impairs circulating proangiogenic granulocytesRoberta Cappellari, Marianna D'Anna, Lisa Menegazzo, et al.
Diabetes Research and Clinical Practice|August 28, 2021
Outcomes of patients with type 2 diabetes treated with SGLT-2 inhibitors versus DPP-4 inhibitors. An Italian real-world study in the context of other observational studiesEnrico Longato, Benedetta Maria Bonora, Barbara Di Camillo, et al.
European Heart Journal|January 1, 2020
Circulating stem cells and cardiovascular outcomes: from basic science to the clinicGian Paolo Fadini, Anurag Mehta, Devinder Singh Dhindsa, et al.
Diabetes Care|June 28, 2015
Effects of Age, Diabetes, and Vascular Disease on Growth Differentiation Factor 11: First-in-Human StudyGian Paolo Fadini, Lisa Menegazzo, Benedetta Maria Bonora, et al.
Cardiovascular Diabetology|April 6, 2017
Effects of the SGLT2 inhibitor dapagliflozin on HDL cholesterol, particle size, and cholesterol efflux capacity in patients with type 2 diabetes: a randomized placebo-controlled trialGian Paolo Fadini, Benedetta Maria Bonora, Giancarlo Zatti, et al.
Pageof 5